Evidence map›Paper›PMID 25999223›Full record

ReviewInfectious disease clinics of North America2015

Diagnosis and treatment of Lyme arthritis.

Sheila L Arvikar, Allen C Steere

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Infectious disease clinics of North America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07351721 (Borrelia Arthritis - a Hidden Cause of Arthritis in Danish Patients? Sub-study 1), which is not on this map. Cited by 114 papers.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07351721 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Borrelia Arthritis - a Hidden Cause of Arthritis in Danish Patients? Sub-study 1:Incidence&Outcomes Sub-study 2:Characterisation

Typeobservational_patient_registrySponsorFredrikke Christie KnudtzenRan2026 to 2028Enrolled350ConditionsLyme ArthritisArmsSynovial fluid Borrelia burgdorferi PCR
3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 223 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Lyme borreliosis.Nature reviews. Disease primers · 2026
    Review
  6. Frontiers in immunology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Borrelia surface proteins: new horizons in Lyme disease diagnosis.Applied microbiology and biotechnology · 2025
    Review
  11. The peptidoglycan ofScience translational medicine · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Synthesis of aMolecules (Basel, Switzerland) · 2024
    Article
  19. Review
  20. Article

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sheila L ArvikarCenter for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA.
Allen C SteereCenter for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA. Electronic address: asteere@mgh.harvard.edu.
Massachusetts General Hospital · US

Funding

Borrelia burgdorferi-Induced Autoimmunity in Lyme DiseaseR01AI101175 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI STEERE, ALLEN C · 2013 to 2021
$3.6M
NIAID NIH HHS R01 AI101175
6 · The paper itself

Abstract

In the United States, Lyme arthritis is the most common feature of late-stage Borrelia burgdorferi infection, usually beginning months after the initial bite. In some, earlier phases are asymptomatic and arthritis is the presenting manifestation. Patients with Lyme arthritis have intermittent or persistent attacks of joint swelling and pain in 1 or a few large joints. Serologic testing is the mainstay of diagnosis. Synovial fluid polymerase chain reaction for B burgdorferi DNA is often positive before treatment, but is not a reliable marker of spirochetal eradication after therapy. This article reviews the clinical manifestations, diagnosis, and management of Lyme arthritis.

Indexed as

Borrelia burgdorferiAnti-Bacterial AgentsAnti-Inflammatory AgentsArthritis, InfectiousHumansLyme DiseasePolymerase Chain ReactionSynovial FluidSynovitisAnti-Bacterial AgentsAnti-Inflammatory AgentsAntibiotic-refractory arthritisBorrelia burgdorferiInflammatory arthritisLyme arthritisLyme disease

Identifiers

PMID25999223
PMCPMC4443866
OpenAlexW1732905722

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.